Aroa Biosurgery Limited 

$0.52
4
+$0.02+4.4% Monday 20:00

Statistics

Day High
0.5
Day Low
0.5
52W High
0.52
52W Low
0.24
Volume
35,000
Avg. Volume
16
Mkt Cap
180.11M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Oct 12
$0.11
Jul 12
$0.11
Apr 12
$0.11
Nov 7
$0.06
Nov 6
$0.06
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

31MayExpected
Q1 2024
Q3 2024
Q1 2025
Q3 2025
Next
-0.01
-0
0
0.01
Expected EPS
0.0057437
Actual EPS
N/A

Financials

-4.61%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
98.7MRevenue
-4.55MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AROAF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc offers medical technologies, services, and solutions, including surgical products that compete with Aroa's biosurgery offerings.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its subsidiary Ethicon, produces surgical products and wound care devices that directly compete with Aroa's biosurgery technologies.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical and surgical equipment, including wound management and surgical solutions that overlap with Aroa's product lines.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation provides medical devices that are used in various surgical applications, competing in the same space as Aroa Biosurgery.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, potentially competing with Aroa's advanced wound care and surgical products.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories manufactures medical devices and healthcare products that can be used in surgical settings, overlapping with Aroa's market.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. specializes in musculoskeletal healthcare, including surgical solutions that can compete with Aroa's offerings.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. provides a broad range of hospital and surgical products, directly competing with Aroa Biosurgery in the healthcare market.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences Holdings Corporation offers products in regenerative technology, neurosurgery, and reconstructive surgery, competing with Aroa's regenerative tissue products.

About

Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine that delivers a bolus of biologically important ECM proteins to help kick start and sustain healing; and Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds. The company also develops products for abdominal wall reconstruction, hernia repair, and breast reconstruction in North America and Europe. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.
Show more...
CEO
Dr. Brian Ward B.V.Sc, MBA(dist)
Country
NZ
ISIN
NZARXE0001S1

Listings

0 Comments

Share your thoughts

FAQ

What is Aroa Biosurgery Limited stock price today?
The current price of AROAF is $0.52 USD — it has increased by +4.4% in the past 24 hours. Watch Aroa Biosurgery Limited stock price performance more closely on the chart.
What is Aroa Biosurgery Limited stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aroa Biosurgery Limited stocks are traded under the ticker AROAF.
What is Aroa Biosurgery Limited market cap?
Today Aroa Biosurgery Limited has the market capitalization of 180.11M
When is the next Aroa Biosurgery Limited earnings date?
Aroa Biosurgery Limited is going to release the next earnings report on May 31, 2026.
What were Aroa Biosurgery Limited earnings last quarter?
AROAF earnings for the last quarter are -0 USD per share, whereas the estimation was 0.01 USD resulting in a -131.67% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aroa Biosurgery Limited revenue for the last year?
Aroa Biosurgery Limited revenue for the last year amounts to 98.7M USD.
What is Aroa Biosurgery Limited net income for the last year?
AROAF net income for the last year is -4.55M USD.
Does Aroa Biosurgery Limited pay dividends?
Yes, AROAF dividends are paid quarterly. The last dividend per share was 0.11 USD. As of today, Dividend Yield (FWD)% is 0%.
When did Aroa Biosurgery Limited complete a stock split?
Aroa Biosurgery Limited has not had any recent stock splits.
Where is Aroa Biosurgery Limited headquartered?
Aroa Biosurgery Limited is headquartered in Auckland, NZ.